Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
296.74 Down 3.40(1.13%) Apr 17, 4:00PM EDT
|After Hours : 296.75 Up 0.01 (0.00%) Apr 17, 5:20PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Oct 8, 2013Stock Traders DailyThomas H Kee Jr.Trading Report for (REGN). A detailed report, including free correlated market analysis, and updates.5$57.50
Sep 30, 2013Stock Traders DailyThomas H Kee Jr.The Investment Rate - a measure of investment demand.43$494.50
Oct 6, 2013Pechala's ReportsLubomir PechalaREGENERON PHARMACEUTICALS INC (REGN) - REPORT FOR ACTIVE TRADERS1$25
Oct 8, 2013New Constructs, LLCN/AREGN: Due Diligence Review: Forensic Earnings and Valuation13$25
Oct 3, 2013Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of REGENERON PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Oct 2, 2013ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for REGN11$25
Dec 18, 2013ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Aug 22, 2013Alpha Street ResearchHunter OrrREGN - Regeneron Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR Ranking Report9$24
Oct 4, 2013S&P Capital IQ – STARS ReportsN/ARegeneron Pharmaceuticals11$126.50
Oct 4, 2013Pechala's ReportsFrantisek PechalaREGENERON PHARMACEUTICALS INC (REGN) 12-months forecast1$15

View All Reports for REGN ...